CSIMarket
 


Innoviva Inc   (INVA)
Other Ticker:  
 


Innoviva Inc 's ROA from the third quarter of 2023 to the third quarter of 2022 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Innoviva Inc 's ROA in the third quarter of 2023?
Innoviva Inc achieved a return on average assets (ROA) of 22.75 % in its third quarter of 2023, which is below Innoviva Inc 's average return on assets, which stands at 24.25%.

ROA has improved compared to 17.98% in the first quarter of 2023, due to net income growth.

However, within the Healthcare sector 56 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the first quarter of 2023 from 106 to 111.

What is ROA?


Return On Assets (Sep 30 2023)
III. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
Y / Y Total Assets Change 4.7 % 2.05 % 32.97 % 49.83 % 44.22 %
Y / Y Net Income Change 283.91 % -7.91 % - 123.43 % -80.72 %
Net Income (TTM) in million 278 217 220 334 208
Return On Assets (TTM) 22.75 % 17.98 % 18.32 % 29.68 % 20.44 %
INVA's Total Ranking # 111 # 106 # 126 # 109 # 110
Total Assets (TTM) in million 1,192 1,132 1,233 1,329 1,138
Seq. Total Assets Change 5.29 % -8.23 % -7.22 % 16.8 % 2.63 %
Seq. Net Income Change 135.32 % - - 973.17 % -43.55 %



Return On Assets Company Ranking
Within: No.
Industry # 29
Sector # 57
Overall # 270

Return On Assets Statistics
High Average Low
112.77 %
24.25 %
-36.1 %
(Dec 31 2018)   (June 30. 2014)





Financial Statements
Innoviva Inc 's Assets $ 1,192 million INVA's Balance sheet
Innoviva Inc 's Income $ 82 million Quarterly INVA's Income Statement
INVA's Income by Division See INVA's Income by Division



Annual Return On Assets (Dec 31 2022)
FY 2022
(Dec 31 2021)
FY 2021
(Dec 31 2020)
FY 2020
(Dec 31 2019)
FY 2019
(Dec 31 2018)
FY 2018
Y / Y Total Assets Change 32.97 % -7.19 % 37.98 % 32.12 % 49.23 %
Total Assets in million 1,233 928 999 724 548
Y / Y Net Income Change -40.28 % 25.53 % 53.83 % -53 % 202.62 %
Net Income in million 220 369 294 191 406
Return On Assets 17.86 % 39.77 % 29.4 % 26.37 % 74.12 %




Comment on INVA's ROA in the fiscal year ending 2022
In the fiscal year 2022 Innoviva Inc 's ROA decreased compared to previous year to 17.86 %, due to deterioration of net income -40.28 % to $220.26 million, from $368.84 million a year ago, as INVA's assets were $1,233.33 million.


More Return On Assets Ratios
INVA's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
INVA's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Roa for INVA's Competitors
Roa for Innoviva Inc 's Suppliers
Return On Assets for INVA's Customers

You may also want to know
INVA's Roi INVA's Inventory Turnover Ratio INVA's Growth Rates INVA's Dividend Comparisons
INVA's Profitability Ratios INVA's Asset Turnover Ratio INVA's Dividend Growth
INVA's Roe INVA's Valuation Ratios INVA's Financial Strength Ratios INVA's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2023, within Healthcare Sector ROA
Ocuphire Pharma Inc   59.88 %
Dariohealth Corp   50.84 %
Harpoon Therapeutics Inc   44.55 %
Entera Bio Ltd   43.08 %
Cortexyme Inc   35.73 %
Star Equity Holdings Inc   34.97 %
Elite Pharmaceuticals Inc   34.57 %
Zymeworks Inc   34.09 %
Fusion Pharmaceuticals Inc   33.31 %
Mei Pharma Inc   32.68 %
One World Products Inc   29.91 %
Janone Inc   29.68 %
Singular Genomics Systems Inc   29.65 %
Synaptogenix Inc   28.70 %
Idexx Laboratories Inc  28.59 %
Malachite Innovations Inc   27.75 %
Avalo Therapeutics Inc   27.43 %
Semler Scientific Inc   27.21 %
Ladrx Corporation  27.12 %
Shockwave Medical Inc   26.44 %
Enzo Biochem Inc  25.81 %
Mettler toledo International Inc   25.66 %
Denali Therapeutics Inc   24.40 %
Innoviva Inc   22.80 %
National Research Corporation  22.18 %
Arcturus Therapeutics Holdings Inc   21.96 %
Exagen Inc   20.92 %
Harmony Biosciences Holdings inc   20.60 %
Iradimed Corporation  19.79 %
Medpace Holdings Inc   19.37 %


Date modified: 2023-11-02T13:11:55+00:00


Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com